Improved Drug Susceptibility Testing (DST) for Mycobacteria
The National Institute of Allergy and Infectious Diseases (NIAID) seeks to advance its mission by supporting research to develop improved drug susceptibility tests (DSTs) for mycobacterial drugs, including those currently used for treatment of tuberculosis (TB) and clinically important non-tuberculous mycobacterial…
| From | National Institutes of Health |
|---|---|
| Who can apply | state governments, counties, cities and townships, special districts (water, fire, parks, etc.), school districts, public colleges and universities and 9 more types |
| Eligibility notes | Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. |
| How much | about 3 awards; $3 million total |
| Deadline | Fri, May 28, 2027 (estimated) (216 days left) |
| Category | Health |
| Type | Cooperative agreement |
| Opportunity # | RFA-AI-28-018 |
| Assistance listing | 93.855 |
| Posted | Wed, Jun 24, 2026 |
Heads-up: Forecast: not open yet. Dates and amounts are the agency's estimates.